Some studies have suggested that the treatment strategy for patients with elevated LDH levels may be to combine immune checkpoint inhibitors and vascular endothelial growth factor (VEGF) inhibitors or tumor reduction therapy [46]. The gene discussed is VEGFA; the disease is neoplasm.